Autopsy report · NCT04870073

Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery

“Financial support could not be obtained for the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Hamilton Health Sciences Corporation

Sponsor type

University, hospital or other

Conditions

Hemodilution; Coronary Artery Disease; Fluid Overload

Interventions

Retrograde autologous priming; Mannitol; Conventional Priming

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• BAFF Levels and Lupus Nephritis (LN)
  “Legal problems with financial support, The study never began” (78% match in meaning)
• Health Education for Physiotherapy in Soccer Players
  “The study was stopped by insufficient funds” (78% match in meaning)
• Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
  “The study withdrawn due to lack financial support” (78% match in meaning)
• Selenium Supplementation of Patients With Cirrhosis
  “Insufficient funds to complete study.” (77% match in meaning)
• Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
  “The study was withdrawn due to lack of financial support.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.